In one of the case reports, a 75-year-old White man with hereditary coagulopathy presented with myasthenic crisis in the setting of acute pulmonary embolism. Chronic symptoms included diplopia, ptosis ...

Taiwan’s REGiMMUNE and Europe-based Kiji Therapeutics are merging to create a globally minded regulatory T-cell biotech that ...

We recently published a list of 8 High Growth High Margin Stocks to Invest In Now. In this article, we are going to take a ...

Scientists have discovered a new process in our immune systems that leads to the production of an important family of anti-viral proteins called interferons. They hope the discovery will now lead to ...

In a perspective article published in Science, Professor Jonathan Rivnay explores next-generation bioelectronic medication.

STAT reporters discuss investors' interest in autoimmune disease, GLP-1 supply issues, and big moments from #STATSummit.

Plasma exchange therapy, typically used to treat rare autoimmune disorders, is becoming a trendy longevity procedure. Here's ...

Anti-NMDAR encephalitis is a rare autoimmune disorder that may be misdiagnosed as schizophrenia. Now, CSHL Professor Hiro ...

First patient dosed with ISP-001 shows reduced urinary GAG level, functional improvements surpassing enzyme replacement ...

Living drugs like these are costly. By using donor cells, the new study hints we might be able to mass produce them in the ...